Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate

American Journal of Clinical Nutrition

Volumn 68, Issue 3, 1998, Pages 591-598

  Lavin, Jacquelynne H ^b   Wittert, Gary A ^a   Andrews, Jane ^b   Yeap, Bu ^b   Wishart, Judith M ^b   Morris, Howard A ^b   Morley, John E ^b   Horowitz, Michael ^b   Read, Nicholas W ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b NONE

Author keywords

Gastric inhibitory polypeptide; GIP; GLP 1; Glucagon like peptide 1; Glucose; Incretin hormones; Insulin; Men; Satiety; Small intestine; Somatostatin

Indexed keywords

CARBOHYDRATE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INSULIN; SOMATOSTATIN;

ADULT; APPETITE; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; FOOD INTAKE; GLUCOSE INFUSION; HORMONE DETERMINATION; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; SATIETY; SMALL INTESTINE;

EID: 0031719462     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.3.591     Document Type: Article

References (45)

1. Habener JF. The incretin concept and its relevance to diabetes. Endocrinol Metab Clin North Am 1993;22:775-94.
2. Lavin JH, Wittert G, Sun W-M, Horowitz M, Morley JE, Read NW. Appetite regulation by carbohydrate: role of blood glucose and gastrointestinal hormones. Am J Physiol 1996;34:E209-14.
3. Byrne MM, Goke B. Human studies with glucagon-like peptide-1; potential of gut hormones for clinical use. Diabet Med 1996;13:854-60.
4. Schirra J, Katschinski M, Weidman C, et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 1996;97:92-103.
5. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996;379:69-72.
6. Mayer J. Glucostatic mechanism of regulation of food intake. N Engl J Med 1953;249:13-6.
7. Mayer J. Regulation of energy intake and body weight. Ann N Y Acad Sci 1955;63:15-43.
8. Russek M. Hepatic receptors and the neurophysiological mechanisms controlling feeding behaviour. Neurosci Res 1971;4:213-82.
9. VanderWeele DA, Novin D, Rezek M, Sanderson JD. Duodenal or hepatic-portal glucose perfusion: evidence for duodenally-based satiety. Physiol Behav 1974;12:467-73.
10. Mei N. Vagal glucoreceptors in the small intestine of the cat. J Physiol 1978;282:485-506.
11. Morley JE. Neuropeptide regulation of appetite and weight. Endocr Rev 1987;8:256-87.
12. Gyr KE, Meier R. Pharmacodynamic effects of sandostatin in the gastrointestinal tract. Digestion 1993;54(suppl):14-9.
13. Lovett D, Booth DA. Four effects of exogenous insulin on food intake. Q J Exp Psychol 1970;22:406-19.
14. Nicolaidis S, Rowland N. Metering of intravenous versus oral nutrients and regulation of energy balance. Am J Physiol 1976; 231:661-8.
15. VanderWeele DA. Insulin is a prandial satiety hormone. Physiol Behav 1994;56:619-22.
16. VanderWeele DA, Haraczkiewicz E, VanItallie TB. Elevated insulin and satiety in obese and normal-weight rats. Appetite 1982; 3:99-109.
17. VanderWeele DA, Pi-Sunyer FX, Novin D, Bush MJ. Chronic insulin infusion suppresses food ingestion and body weight gain in rats. Brain Res Bull 1980;5(suppl):7-11.
18. Woods SC, Stein LJ, McKay LD, Porte D. Suppression of food intake by intravenous nutrients and insulin in the baboon. Am J Physiol 1984;247:R393-401.
19. Booth DA, Brookover T. Hunger elicited in the rat by a single injection of bovine crystalline insulin. Physiol Behav 1968;3:439-46.
20. Brandes JS. Insulin induced overeating in the rat. Physiol Behav 1977;18:1095-102.
21. Kanarek RB, Marks-Kaufman R, Lipeles BJ. Increased carbohydrate intake as a function of insulin administration in rats. Physiol Behav 1980;25:779-82.
22. Rodin J, Wack J, Ferrannini E, DeFronzo RA. Effect of insulin and glucose on feeding behavior. Metab Clin Exp 1985;34:826-31.
23. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83.
24. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin resistance. Am J Physiol 1979; 237:E214-23.
25. Houghton LA, Heddle R, Madderin GJ, et al. A study of the motor activity of the gastric antrum, pylorus and duodenum in fasted and fed human subjects. Gastroenterology 1988;94:1276-84.
26. Sepple CP, Read NW. Gastrointestinal correlates of the development of hunger in man. Appetite 1989;13:183-91.
27. Wishart J, Morris HA, Horowitz M. Radioimmunoassay of gastric inhibitory polypeptide in plasma. Clin Chem 1992;38:2156-7.
28. Kreymann B, Ghatei MA, Williams G, Bloom SR. Glucagon-like-peptide-1 7-36: a physiological incretin in man. Lancet 1987; 2:1300-3.
29. Orskov C, Rabenhoj L, Wittergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of amidated and glycine extended glucagon-like peptide 1 in humans. Diabetes 1994;43:535-9.
30. Hunt JN, Smith JL, Jiang CL. Effect of meal volume and energy density on the gastric emptying of carbohydrates. Gastroenterology 1985;89:1326-30.
31. Welch IM, Cunningham KM, Read NW. Regulation of gastric emptying by ileal nutrients in humans. Gastroenterology 1988;94:401-4.
32. Welch IM, Davidson PA, Worlding J, Read NW. Effect of ileal infusion of lipid on jejunal motor patterns after a nutrient and nonnutrient meal. Am J Physiol 1988;255:G800-6.
33. Lin HC, Doty JE, Reedy TJ, Meyer JH. Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient. Am J Physiol 1989;256:G404-11.
34. Lin HC, Doty JE, Reedy TJ, Meyer JH. Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed to nutrient. Am J Physiol 1990;259:G1031-6.
35. Tasaka Y, Sekine M, Wakatsuki M, Ohgawara H, Shizume K. Levels of pancreatic glucagon, insulin and glucose during twenty-four hours of the day in normal subjects. Horm Metab Res 1975;7:205-6.
36. Marchetti P, Scharp DW, McLear M, et al. Insulin inhibits its own secretion from isolated, perfused human pancreatic islets. Acta Diabetologia 1995;32:75-7.
37. Piatti PM, Pontiroli AE, Caumo A, et al. Hyperinsulinemia decreases second-phase but not first-phase arginine-induced insulin release in humans. Diabetes 1994;43:1157-63.
38. Woo R, Kissileff HR, Pi-Sunyer FX. Elevated postprandial insulin levels do not induce satiety in normal-weight humans. Am J Physiol 1984;247:R745-9.
39. Chapman IM, Goble EA, Wittert GA, Horowitz M. Effects of small intestinal fat and carbohydrate infusions on appetite and food intake in obese and nonobese men. Am J Clin Nutr (in press).
40. Furuse M, Matsumoto M, Okumura J, Sugahara K, Hasegawa S. Intracerebroventricular injection of mammalian and chicken glucagon-like peptide-1 inhibits food intake of the neonatal chick. Brain Res 1997;755:167-9.
41. Drewe J, Flicker G, Huwyler J, Gutmann H, Toruk M, Beglinger C. Is peripheral postprandially released glucagon-like peptide able to cross the blood brain barrier. Gastroenterology 1997;112:A1144 (abstr).
42. Gutzwiller JP, Goke B, Drewer J, et al. Glucagon-like peptide is a physiological regulator of food intake in humans. Gastroenterology 1997;112:A1153 (abstr).
43. Naslund E, Gryback P, Hellstrom P, et al. Obese subjects have lower postprandial GLP-1 values and a faster rate of gastric emptying than normal weight subjects. Gastroenterology 1997;112:A1176 (abstr).
44. Eissele R, Goke R, Willemer S, et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 1992;22:283-91.
45. Holst JJ. Glucagon like peptide-1 - a newly discovered gastrointestinal hormone. Gastroenterology 1994;107:1848-55.